ABSTRACT
Injectables were initially a result of research following the war, when Dr Junkman found in 1953 that a long-acting injection was created if progestogen and alcohol were combined.
In 1957 research began on the injectable Norigest, now known as Noristerat, which is licensed for short-term use in the UK, i.e. following administration of the rubella vaccine. In 1963 trials commenced on the injectable Depoprovera, which was licensed in the UK for long-term use in 1984 when other methods were not suitable. Since 1990 it has been licensed as a f rst-choice method.
